Treatment and diagnostics craniopharyngioma in Seoul, South Korea

Craniopharyngioma is a benign brain tumor located near the pituitary gland. It is not aggressive and is not prone to malignancy, and it is also characterized by slow growth, which contributes to a long asymptomatic course. As it grows, it may compress structures such as the pituitary gland, the optic nerves, or the optic chiasm, causing vision loss, hormonal imbalance, and other problems. Treatment of craniopharyngioma in Seoul means the experience of the world’s best doctors, advanced technologies, and a guaranteed remission.

Before developing a treatment strategy, doctors in local hospitals carry out thorough diagnostics. It includes an examination by a neurologist, ophthalmologic visual field assessment, extended biochemical and hormonal blood tests, CT and MSCT, MRI, and biopsy under imaging guidance. Procedures are performed using the most modern and safest equipment.

Therapy of craniopharyngioma in Seoul is carried out by the following methods:

• transsphenoidal endoscopic surgery,
• classical craniotomy,
• stereotactic radiosurgery,
• intensity-modulated proton therapy,
• intracavitary (interstitial) radiotherapy.

Sometimes low-dose chemo- or radiotherapy is prescribed to support the result and prevent recurrence. The treatment options practiced in clinics in Seoul are both effective and safe.

Local neurologists work closely with radiologists, oncologists, neurosurgeons, internists, ophthalmologists, and rehabilitation specialists to achieve lasting remission and protect the patient from complications of the disease.